Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Demecan Florestura
- Development stage
- Unknown
- Lead developer
- DEMECAN
- Modality
- Small Molecules
- Administration
- Inhalation, Oral
01
Overview
Demecan Florestura is a medical cannabis flower product distributed in Germany by DEMECAN. It is derived from the Sativa-dominant hybrid cultivar Super Haze X Amnesia, which is cultivated in Australia by Little Green Pharma. The product is available in multiple strengths (such as 16:01, 18:01, 20:01, 22:01, and 24:01), representing the approximate percentage of tetrahydrocannabinol (THC) to cannabidiol (CBD). Its primary active ingredient, THC, acts as a partial agonist at the cannabinoid receptors CB1 and CB2, producing analgesic, muscle-relaxing, antiemetic, and appetite-stimulating effects. Demecan Florestura is prescribed in Germany for the management of chronic pain, anxiety disorders, post-traumatic stress disorder (PTSD), depression, migraines, spasticity, and sleep disorders.
- Brand names
- Demecan 16:01 FloresturaDemecan 18:01 FloresturaDemecan 20:01 FloresturaDemecan 22:01 FloresturaDemecan 24:01 FloresturaDemecan Florestura
- Other names
- Super Haze X Amnesia
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Demecan Florestura.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Demecan Florestura.